Board Remuneration Report FY21
Wexford Hayes guide to Board remuneration for the ASX-listed healthcare and biotechnology sectors is out now. Click on the attached link for some key insights. If interested in a copy please contact us.
Previous
Previous
Board Remuneration Report FY22
Next
Next